0

524414

NORRIS

img img img img
No Data Available

NORRIS MEDICINES LTD. Share Price Update

As of the latest trading session, NORRIS MEDICINES LTD. share price is currently at ₹13.33, which is down by ₹-0.17 from its previous closing. Today, the stock has fluctuated between ₹13.32 and ₹14.00. Over the past year, NORRIS MEDICINES LTD. has achieved a return of -34.91%. In the last month alone, the return has been -6.71%.

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

NORRIS MEDICINES LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    13.30

  • P/E Ratio (TTM)

    -23.80

  • Beta

    0.54

  • Book Value / share

    -15.82

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.70

info icon alternate text

NORRIS MEDICINES LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 3.27
Operating Expense 2.57
Net Profit 0.70
Net Profit Margin (%) 21.40
Earnings Per Share (EPS) 0.70
EBITDA 0.95
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 2.00
Operating Expense 2.71
Net Profit -0.72
Net Profit Margin (%) -36.00
Earnings Per Share (EPS) -0.72
EBITDA -0.49
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 1.46
Operating Expense 1.79
Net Profit -0.31
Net Profit Margin (%) -21.23
Earnings Per Share (EPS) -0.31
EBITDA -0.08
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 2.72
Operating Expense 2.94
Net Profit -0.23
Net Profit Margin (%) -8.45
Earnings Per Share (EPS) -0.23
EBITDA 0.12
Effective Tax Rate (%) -35.29
Particulars DEC 2024 (Values in Cr)
Revenue 1.11
Operating Expense 1.39
Net Profit -0.28
Net Profit Margin (%) -25.22
Earnings Per Share (EPS) -0.28
EBITDA -0.03
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 5.82
Operating Expense 7.06
Net Profit -1.24
Net Profit Margin (%) -21.30
Earnings Per Share (EPS) -1.24
EBITDA -0.19
Effective Tax Rate (%) -5.08
Particulars MAR 2024 (Values in Cr)
Revenue 5.64
Operating Expense 6.76
Net Profit -1.19
Net Profit Margin (%) -21.09
Earnings Per Share (EPS) -1.19
EBITDA -0.16
Effective Tax Rate (%) -8.18
Particulars MAR 2023 (Values in Cr)
Revenue 8.36
Operating Expense 9.57
Net Profit -1.75
Net Profit Margin (%) -20.93
Earnings Per Share (EPS) -1.75
EBITDA 0.94
Effective Tax Rate (%) -47.05
Particulars MAR 2022 (Values in Cr)
Revenue 9.44
Operating Expense 11.65
Net Profit -3.26
Net Profit Margin (%) -34.53
Earnings Per Share (EPS) -3.26
EBITDA -0.04
Effective Tax Rate (%) -49.54
Particulars MAR 2021 (Values in Cr)
Revenue 12.25
Operating Expense 16.29
Net Profit -4.96
Net Profit Margin (%) -40.48
Earnings Per Share (EPS) -4.96
EBITDA -1.69
Effective Tax Rate (%) -24.31
Particulars MAR 2025 (Values in Cr)
Book Value / Share -14.98
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -3.44
Particulars MAR 2024 (Values in Cr)
Book Value / Share -13.73
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -2.84
Particulars MAR 2023 (Values in Cr)
Book Value / Share -12.54
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 11.24
Particulars MAR 2022 (Values in Cr)
Book Value / Share -10.77
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -0.53
Particulars MAR 2021 (Values in Cr)
Book Value / Share -7.49
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -13.88
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 13.80
Total Liabilities 13.80
Total Equity -14.86
Share Outstanding 0
Price to Book Ratio -1.12
Return on Assets (%) -8.96
Return on Capital (%) -18.43
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 14.18
Total Liabilities 14.18
Total Equity -13.63
Share Outstanding 0
Price to Book Ratio -0.99
Return on Assets (%) -8.36
Return on Capital (%) -15.03
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 13.68
Total Liabilities 13.68
Total Equity -12.44
Share Outstanding 0
Price to Book Ratio -0.83
Return on Assets (%) -12.78
Return on Capital (%) -19.52
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 14.19
Total Liabilities 14.19
Total Equity -10.69
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -22.99
Return on Capital (%) -31.43
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 19.78
Total Liabilities 19.78
Total Equity -7.43
Share Outstanding 0
Price to Book Ratio -0.87
Return on Assets (%) -25.07
Return on Capital (%) -61.31
Particulars MAR 2025 (Values in Cr)
Net Income -1.23
Cash from Operations 0.51
Cash from Investing 0.00
Cash from Financing -0.50
Net change in Cash 0.00
Free Cash Flow 0.52
Particulars MAR 2024 (Values in Cr)
Net Income -1.18
Cash from Operations 0.16
Cash from Investing 0.05
Cash from Financing -0.20
Net change in Cash 0.01
Free Cash Flow 0.17
Particulars MAR 2023 (Values in Cr)
Net Income -1.74
Cash from Operations 1.19
Cash from Investing -0.02
Cash from Financing -1.17
Net change in Cash 0.00
Free Cash Flow 1.22
Particulars MAR 2022 (Values in Cr)
Net Income -3.26
Cash from Operations -1.00
Cash from Investing -0.08
Cash from Financing 1.09
Net change in Cash 0.00
Free Cash Flow -0.95
Particulars MAR 2021 (Values in Cr)
Net Income -4.96
Cash from Operations 1.11
Cash from Investing -0.06
Cash from Financing -1.09
Net change in Cash -0.04
Free Cash Flow 1.20
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 26.47 11.46 1.37 202.85 23.12 / 44.78
BLISS GVS PHARMA LTD 223.25 21.34 2.08 2361.74 105.05 / 244.05
CIPLA LTD 1341.45 22.79 3.29 108359.74 1283.00 / 1672.20
FERMENTA BIOTECH LIMITED 323.25 10.75 2.43 951.36 219.00 / 399.00
GLAXOSMITHKLINE PHARMA LT 2600.10 43.79 25.79 44047.26 2220.00 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 26.47 25.45 3.68 202.85 23.12 / 44.78
AMRUTAJAN HEALTH LTD 615.30 30.77 5.20 1778.87 548.05 / 789.95
ASTRAZENECA PHARMA IND LT 8902.90 106.99 27.85 22257.25 6501.60 / 10653.05
BLISS GVS PHARMA LTD 223.25 30.42 2.13 2361.74 105.05 / 244.05

NORRIS MEDICINES LTD. shareholding pattern

Holding

65.93%
33.99%
0.06%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

NORRIS MEDICINES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
13.33 -1.25 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 13.70
  • 26 Days 14.10
  • 10 Days 13.80
  • 50 Days 14.60
  • 12 Days 13.90
  • 100 Days 15.30
  • 20 Days 14.00
  • 200 Days 16.00
13.61 PIVOT

First Support

13.21

First Resistance

13.89

Second Support

12.93

Second Resistance

14.29

Third Support

12.53

Third Resistance

14.57

RSI

43.71

ADX

9.25

MACD

-0.28

Williams % R

-84.77

Commodity Channel Index (CCI)

-58.73

Date

2026-02-20

Week

1057.00

Same Day

51.00

Month

1088.00

1 Year

0.54

3 Year

0.26

Over 1 Month

-6.71%

down

Over 1 Year

-34.91%

down

Over 3 Months

-18.22%

down

Over 3 Years

1.20%

down

Over 6 Months

-22.54%

down

Over 5 Years

17.31%

down

NORRIS MEDICINES LTD. Corporate Actions

Top Gainers

NORRIS MEDICINES LTD. Share Price

Norris Medicines Limited was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments. The Company was subsequently converted into Public Limited Company on March 7, 1992. The unit expanded to manufacture Sterile dosage in form of Ampoules & Vials.

The Company got into the business in the year 1990. Commercial production of the formulation unit commenced in Nov.'91. The production unit expanded to manufacture Sterile dosage in form of Ampoules & Vials. The project commence in March 1992. Thereafter, the Company came out with a Public Issue aggregating Rs. 5 Crore in December, 1993 to expand its existing capacity for tablets, capsules, etc, besides diversifying into bulk drugs and setting up an injectables unit. The project costing Rs 14.21 Crore was financed through loans and equity, which got completed in 1995.

In 2006, the Company launched Diabetic & Cardiac products; launched Dental product in 2007; launched New Molecule Tolperisone with Paracetamol tablet in 2012; in 2013, it extended Anti malarial range with Artemether Lumefantrine tablet & dry syrup. During the year 2013-14, the Company undertook the upgradation of Sterile Injectable Plant.

The Company is one of the leading Indian manufacturers of Injections and Medicinal formulations. The Company is engaged into Health Care Industry and operate 2 plants situated at GIDC, Ankleshwar, Gujarat. Both plants of the Company are WHO GMP approved. At present, it has renovated the Sterile Injectable Plant and with this the plant is now as per international standards.

Parent organization Indian Private
NSE symbol [-]
Founded 1990
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Norris Medicines Ltd?

Answer Field

Norris Medicines Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 13.33 as on Feb 20 2026 03:26 PM.

What is the Market Cap of Norris Medicines Ltd Share?

Answer Field

The market cap of Norris Medicines Ltd for NSE ₹ 0.00 & for BSE ₹ 13.30 as on Feb 20 2026 03:26 PM.

What is the 52 Week High and Low of Norris Medicines Ltd?

Answer Field

The 52 Week High and Low of Norris Medicines Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 22.10 and ₹ 12.50.

What is 1 year return for Norris Medicines Ltd?

Answer Field

The 1 year returns on the stock has been -34.91%.

What is the P/E Ratio of Norris Medicines Ltd Share?

Answer Field

As on Feb 20 2026 03:26 PM the price-to-earnings (PE) ratio for Norris Medicines Ltd share is -23.80.

What is the PB ratio of Norris Medicines Ltd Share?

Answer Field

As on Feb 20 2026 03:26 PM, the price-to-book (PB) ratio for Norris Medicines Ltd share is -15.82.

How to Buy Norris Medicines Ltd Share?

Answer Field

You can trade in Norris Medicines Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Norris Medicines Ltd Share on Bajaj Broking App?

Answer Field

To buy Norris Medicines Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Norris Medicines Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59